Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2007 | 12-2006 | 09-2006 | 12-2005 | 09-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,548 | N/A | -8,068 | N/A | -3,383 |
| Depreciation Amortization | 254 | N/A | 241 | N/A | 189 |
| Accounts payable and accrued liabilities | 830 | N/A | 1,295 | N/A | 33 |
| Other Working Capital | 2,561 | N/A | 2,074 | N/A | 334 |
| Other Operating Activity | 3,394 | 0 | 534 | 0 | 435 |
| Operating Cash Flow | $-15,509 | $N/A | $-3,924 | $N/A | $-2,392 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,315 | N/A | -180 | N/A | -551 |
| Purchase Sale Intangibles | -66 | N/A | -161 | N/A | -44 |
| Other Investing Activity | -66 | 0 | -161 | 0 | -44 |
| Investing Cash Flow | $-1,381 | $N/A | $-341 | $N/A | $-595 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -154 | N/A | 154 |
| Common Stock Issued | 80,641 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,268 | 0 | 21,590 | 0 | 2,980 |
| Financing Cash Flow | $79,373 | $N/A | $21,436 | $N/A | $3,134 |
| Beginning Cash Position | 17,539 | N/A | 368 | N/A | 221 |
| End Cash Position | 80,022 | N/A | 17,539 | N/A | 368 |
| Net Cash Flow | $62,483 | $N/A | $17,171 | $N/A | $147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,509 | N/A | -3,924 | N/A | -2,392 |
| Capital Expenditure | -1,315 | N/A | -180 | N/A | -551 |
| Free Cash Flow | -16,824 | 0 | -4,104 | 0 | -2,943 |